POST Online Media Lite Edition



 

Pulmatrix: Eva Jack named chief business officer

Staff writer |
Cambridge, Mass., USA - December 14, 2010, Cambridge, Mass., USA - Pulmatrix, a biotechnology company, announced the appointment of Eva Jack as chief business officer.

Article continues below





Ms. Jack most recently served as Managing Director at MedImmune Ventures, the corporate venture fund of MedImmune, LLC, which included serving as a board member or board observer for several portfolio companies.

Ms. Jack initially joined MedImmune’s business development group serving as Director and Associate Director, completing numerous in-licensing and out-licensing transactions.

Prior to her tenure at MedImmune, Ms. Jack held various senior leadership positions at Intel Corporation, including Senior Manager of Strategic Investments.

LATEST 5 MOVES FROM Massachusetts 


What to read next

Pulmatrix appoints Mark Iwicki as chairman
Pulmatrix apoints William Duke, Jr. as CFO
Pulmatrix names Robert Clarke CEO